## Abstract Alzheimer's disease (AD) is a neurodegenerative disease that leads to a progressive loss of integrative and memory capacities of the brain. This is the predominant form of neurodegenerative dementia, with a growing prevalence of between 1 in 50 and 1 in 100 in North America. Numerous hy
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
✍ Scribed by Rudie Kortekaas; Klaus L. Leenders; Joost C. H. van Oostrom; Willem Vaalburg; Joost Bart; Antoon T. M. Willemsen; N. Harry Hendrikse
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 158 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Objective: The overall permeability of the blood-brain barrier (BBB) is regulated by specialized cerebral endothelial cells and their junctional complexes, consisting of adherens junctions (AJs) and tight junctions (TJs). Among the members of the glucose transporters (Glut), Glut1 is a unique molecu
## Abstract The morphofunctional preservation of the blood–brain barrier (BBB) was evaluated in the isolated guinea pig brain maintained in vitro by arterial perfusion. Electron microscopy evaluation after 5 hr in vitro demonstrated that cerebral capillaries and BBB specializations in this preparat
## Abstract Brain ischemia is associated with an acute release of pro‐inflammatory cytokines, notably TNF‐α and IL‐6 and failure of the blood–brain barrier. Shear stress, hypoxia‐hypoglycemia, and blood leukocytes play a significant role in blood–brain barrier failure during transient or permanent